Enhanced sMICA and TGF-β1 plasma levels in HNSCC patients also correlated strongly with NKG2D-dependent dysfunction of patient NK cells, resulting in suppressed killing activity against HNSCC cells and decreased NK cell viability during cytotoxic effector-target interactions. Here, KLRK1 is linked to head and neck squamous cell carcinoma.